Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2014-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47f4410c1fc39d00bc9e8e266f2cb3ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b34d5809afa6ee95d16bd76ffe2e3d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ac38f9ff4e7d61793a976d95c180916 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2bc8c3c4121ff46508c89963f80127d |
publicationDate |
2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014145576-A2 |
titleOfInvention |
Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer |
abstract |
Disclosed are substituted pyrrolo[23-d]pyvimidke compounds. The disclosed compoimds are shown to be 'useful in inhibiting the growth of cancer cell lines and treating cancer and cell, proliferative disorders. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017088289-A1 |
priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |